John D T, Weik R R, Adams A C
Infect Immun. 1977 Jun;16(3):817-20. doi: 10.1128/iai.16.3.817-820.1977.
Naegleria fowleri produces fatal meningoencephalitis in humans and in experimentally infected laboratory animals. The course of the disease in mice is dependent upon the infecting dose of amoebae, route of inoculation, and prior exposure to Naegleria antigens. DUB/ICR mice were immunized by various routes and antigen preparations, held for 21 days, and, together with noninfected control mice, challenged intravenously (i.v.) or intranasally (i.n.) with 10(7) or 10(6) N. fowleri per mouse, respectively. Mice immunized with liver or formalinized N. fowleri or live N. gruberi subcutaneously, intraperitoneally, i.v., or i.n. were significantly protected against a subsequent lethal challenge with N. fowleri i.v. or i.n. In general, i.v. inoculation afforded greated protection than other routes of immunization, intact cells immunized mice better than did cell fragments, and N. gruberi appeared to be a better immunogen than N. fowleri.
福氏耐格里阿米巴可在人类以及实验感染的实验动物中引发致命性脑膜脑炎。小鼠的病程取决于阿米巴的感染剂量、接种途径以及之前是否接触过耐格里阿米巴抗原。将DUB/ICR小鼠通过各种途径和抗原制剂进行免疫,饲养21天,然后分别与未感染的对照小鼠一起,每只小鼠静脉注射(i.v.)或鼻内注射(i.n.)10⁷或10⁶个福氏耐格里阿米巴。用肝脏、福尔马林固定的福氏耐格里阿米巴或活的格氏耐格里阿米巴进行皮下、腹腔内、静脉内或鼻内免疫的小鼠,对随后静脉注射或鼻内注射福氏耐格里阿米巴的致死性攻击具有显著的抵抗力。一般来说,静脉接种比其他免疫途径提供了更好的保护,完整细胞免疫的小鼠比细胞碎片免疫的小鼠效果更好,并且格氏耐格里阿米巴似乎比福氏耐格里阿米巴是更好的免疫原。